Featured Research

from universities, journals, and other organizations

Sea Anemone Toxin Halts Experimental Multiple Sclerosis; Findings May Lead To New Treatments For Disease

Date:
November 21, 2001
Source:
University Of California-Irvine
Summary:
Sea anemones use venom to stun their prey, but one component of that venom halts -- and may reverse -- the paralysis seen in an experimental form of multiple sclerosis, according to a study by UC Irvine's College of Medicine and the University of Marseilles, France.

Sea anemones use venom to stun their prey, but one component of that venom halts--and may reverse--the paralysis seen in an experimental form of multiple sclerosis, according to a study by UC Irvine's College of Medicine and the University of Marseilles, France.

If the findings conducted on rats prove effective in humans, they could result in a new class of drug treatments for multiple sclerosis, one of the most common diseases of the nervous system, known for its devastating and progressive loss of sensation and function. The study appears in the Nov. 20 issue of the Proceedings of the National Academy of Sciences.

Christine Beeton and Heike Wulff, physiology and biophysics researchers, and their colleagues found that a component of venom called ShK from the Caribbean sea anemone Stichodactyla helianthus blocks ion channels located in white blood cells that had been activated to cause an experimental form of multiple sclerosis called EAE. By blocking the channels on these activated cells, ShK prevented the activated cells from attacking the nervous system and causing paralysis.

The white blood cells, also known as T cells, that were activated to cause experimental MS, contained unusually high numbers of a particular ion channel. Usually, such inappropriately activated cells are destroyed by the body's thymus gland, which regulates production of immune cells. But in many cases of multiple sclerosis, these disease-causing cells slip through and can attack nerve cells. Ion channels are found on the surface of cells and play crucial roles in communicating between cells and regulating cellular behavior.

"This experimental form of multiple sclerosis is caused by T cells with high numbers of unique ion channels that may trigger the T cells into attacking neurons and eventually cause paralysis and death," said Beeton. "Our experiments show that we can block these channels, and only these channels, and protect neurons from damage. If these findings hold after testing in other animals and people, they may result in an effective treatment for MS."

Multiple sclerosis is a debilitating disease in which T cells and other components of the immune system literally attack their own nervous system, resulting in tremors, burning, sensory deprivation, paralysis and eventually death. Immune cells cause the disease by stripping away a protective sheath called myelin that normally surrounds neurons and helps them transmit crucial nerve signals.

The disease can strike the young and elderly and can take years to develop. The National Multiple Sclerosis Society estimates that between 250,000 and 350,000 people in the United States suffer from multiple sclerosis. There is no known cure, though certain treatments can address symptoms and even slow the disease's course if detected early.

ShK blocked the ion channels and stopped the activated cells' destructive activity. By continuously blocking these T cell channels with ShK, the researchers found they could reverse the experimental disease, even after the initial onset of symptoms. In some rats that were showing signs of paralysis, their function was nearly fully restored.

ShK is the most potent inhibitor known for these channels on the activated T cells, but its short life span in the bloodstream reduces its effectiveness as a therapeutic drug.

"ShK may not last long enough to prevent or treat disease on a long-term basis," Wulff said. "But it appears to match the biochemical structure of the channel well enough to block it and change the T cells' responses. Our group is searching for chemically similar substances that last longer in the body."

"This research shows that we may be able to effectively treat the disease while preserving the immune system by targeting a specific cellular ion channel," Beeton said. "Still, researchers will have to find out what dose works best to treat MS, whether it can work on other illnesses and at what stage of a disease treatment should begin."

The researchers' work was supported by the National Multiple Sclerosis Society, the French Association pour la Recherche sur La Sclérose en Plaques, Fondation pour la Recherche Medicale and the U.S. National Institutes of Health.

Beeton's and Wulff's colleagues in the study include Michael Cahalan and George Chandy at UCI, Jocelyne Barbaria, Olivier Clot-Faybesse, Dominique Bernard and Evelyne Béraud of the Faculté de Médecine, Marseilles, France, and Michael Pennington of Bachem Bioscience, King of Prussia, Pa. Béraud's team at the University of Marseilles induced the experimental form of MS in the rats. Michael Pennington and his team at Bachem synthesized the ShK venom component that was used in the study.


Story Source:

The above story is based on materials provided by University Of California-Irvine. Note: Materials may be edited for content and length.


Cite This Page:

University Of California-Irvine. "Sea Anemone Toxin Halts Experimental Multiple Sclerosis; Findings May Lead To New Treatments For Disease." ScienceDaily. ScienceDaily, 21 November 2001. <www.sciencedaily.com/releases/2001/11/011120054320.htm>.
University Of California-Irvine. (2001, November 21). Sea Anemone Toxin Halts Experimental Multiple Sclerosis; Findings May Lead To New Treatments For Disease. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2001/11/011120054320.htm
University Of California-Irvine. "Sea Anemone Toxin Halts Experimental Multiple Sclerosis; Findings May Lead To New Treatments For Disease." ScienceDaily. www.sciencedaily.com/releases/2001/11/011120054320.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) — A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) — A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) — Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) — The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins